Skip to main content
Premium Trial:

Request an Annual Quote

Athersys Gets Rights to Minnesota Stem Cells

NEW YORK, Dec. 11-Athersys has obtained exclusive rights to University of Minnesota stem cell technology in order to study stem cell differentiation and develop new therapeutics, the company said this morning.


The company acquired rights to research done with Multipotent Adult Progenitor Cells, a type of stem cell isolated from adult bone marrow. Stem cell researchers hope these may be developed as a treatment for conditions like muscular dystrophy or Parkinson's disease.


In this agreement, researchers from Athersys and from the University of Minnesota hope to jointly identify the proteins that direct cell differentiation using the company's gene expression technology. These proteins may also suggest new leads for drug development.


The partners are making the cells available to academic researchers through material transfer agreements.


Financial specifics of the license and partnership were not revealed.


Athersys is based in Cleveland, Ohio.


For further information, see the statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.